Cargando…
Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC(®) Natural Adjuvant against Aspergillosis
Invasive pulmonary aspergillosis represents one of the most serious fungal infections among immunocompromised patients. In this study, we aimed to analyze the in vivo efficacy of prophylactic oral amphotericin B (AMB) encapsulated in modified chitosan-nanoparticles (Nanomerics’ Molecular Envelope Te...
Autores principales: | Pérez-Cantero, Alba, Serrano, Dolores R., Navarro-Rodríguez, Patricia, Schätzlein, Andreas G., Uchegbu, Ijeoma F., Torrado, Juan J., Capilla, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781303/ https://www.ncbi.nlm.nih.gov/pubmed/31484389 http://dx.doi.org/10.3390/pharmaceutics11090456 |
Ejemplares similares
-
Amphotericin B Polymer Nanoparticles Show Efficacy against Candida Species Biofilms
por: Alakkad, Abdulghani, et al.
Publicado: (2022) -
Nucleotides and AHCC Enhance Th1 Responses In Vitro in Leishmania-Stimulated/Infected Murine Cells
por: Dea-Ayuela, María Auxiliadora, et al.
Publicado: (2020) -
Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters
por: Mellor, Ryan D., et al.
Publicado: (2021) -
Effects of AHCC® on Immune and Stress Responses in Healthy Individuals
por: Takanari, Jun, et al.
Publicado: (2018) -
Antifungal and Antiparasitic Drug Delivery
por: Torrado, Juan José, et al.
Publicado: (2020)